Document Detail

The effect of local angiotensin converting enzyme inhibition on the action of atrial natriuretic peptide in the human forearm.
MedLine Citation:
PMID:  2542549     Owner:  NLM     Status:  MEDLINE    
It has been suggested that angiotensin converting enzyme (ACE) may play a role in the metabolism of atrial natriuretic peptide (ANP), and that ANP may interfere with angiotensin-induced vasoconstriction. This has been investigated within the forearm vascular bed during local ANP infusion and ACE inhibition. Six normotensive volunteers were studied, each on two occasions. On both occasions, after saline infusion, volunteers were given initially a 20 min infusion of ANP at 0.1 microgram/min via the brachial artery. This was followed, after 20 min, by a second infusion of ANP at the same dose, co-infused with enalaprilat (5 micrograms/min) on one occasion, and placebo (saline) on the other (in random order). Forearm blood flow was measured using venous occlusion plethysmography with mercury-in-silastic strain gauges. Blood flow in the cannulated arm increased significantly during the first ANP infusion; by 52 +/- 15% before placebo (P less than 0.05), and by 41 +/- 8% before enalaprilat (P less than 0.005). This increase was similar with the second ANP infusion during co-infusion of either placebo (40 +/- 10%) or enalaprilat (45 +/- 11%). Enalaprilat did not affect the half-life of vasodilatation produced by ANP (t1/2 = 5 min). These studies in healthy subjects demonstrate no effect of local ACE inhibition on resting blood flow, or on the vasodilatation produced by ANP in the human forearm, and provide no evidence of a role of ACE in the metabolism of ANP in this vascular bed.
J R Cockcroft; M J Allen; N Benjamin; D J Webb
Related Documents :
2542549 - The effect of local angiotensin converting enzyme inhibition on the action of atrial na...
6794679 - Influence of sex difference and oral contraceptives on forearm reactive hyperemia.
1561979 - Reversal of endothelin-1-induced vasoconstriction by nifedipine in human resistance ves...
914099 - Cigarette smoking: impairment of digital blood flow and wound healing in the hand.
11605769 - Transdermal estrogen replacement therapy and vasomotor response.
12760989 - Sympathetic and vascular consequences from remifentanil in humans.
11394489 - Effects of electroacupuncture on blood-brain barrier after cerebral ischemia-reperfusio...
21902869 - The efficacy of novel arylimidamides against trypanosoma cruzi in vitro.
8708759 - Regional myocardial perfusion assessed with generator-produced copper-62-ptsm and pet.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of human hypertension     Volume:  3     ISSN:  0950-9240     ISO Abbreviation:  J Hum Hypertens     Publication Date:  1989 Feb 
Date Detail:
Created Date:  1989-06-28     Completed Date:  1989-06-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  49-52     Citation Subset:  IM    
Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Atrial Natriuretic Factor / metabolism*
Enalapril / analogs & derivatives,  pharmacology
Forearm / blood supply*,  drug effects
Regional Blood Flow / drug effects
Vasodilation / drug effects*
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 75847-73-3/Enalapril; 84680-54-6/Enalaprilat; 85637-73-6/Atrial Natriuretic Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Headache and blood pressure: evidence of a close relationship.
Next Document:  The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsych...